Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer.

Ayana ShikanaiYoshiya HorimotoYumiko IshizukaToshitaka UomoriKatsuya NakaiAtsushi ArakawaMitsue Saito

Published in: Breast cancer : basic and clinical research (2022)

Our data indicate that tumour grade in primary lesion and NLR are potential predictive factors for CDKi-based treatments. Moreover, pathological assessment of metastatic lesions might also be useful.

Keyphrases

metastatic breast cancer
squamous cell carcinoma
small cell lung cancer
electronic health record
cell cycle
big data
machine learning
cell proliferation
artificial intelligence